000 01276 a2200385 4500
005 20250513221236.0
264 0 _c20001005
008 200010s 0 0 eng d
022 _a0004-8380
024 7 _a10.1111/j.1440-0960.1997.tb01014.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCebon, J
245 0 0 _aImmunotherapy of melanoma: targeting defined antigens.
_h[electronic resource]
260 _bThe Australasian journal of dermatology
_cJun 1997
300 _aS66-72 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntigens, Neoplasm
_xanalysis
650 0 4 _aCancer Vaccines
_xadministration & dosage
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunity
650 0 4 _aImmunohistochemistry
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMale
650 0 4 _aMelanoma
_ximmunology
650 0 4 _aPrognosis
650 0 4 _aSkin Neoplasms
_ximmunology
650 0 4 _aTreatment Outcome
700 1 _aMacGregor, D
700 1 _aScott, A
700 1 _aDeBoer, R
773 0 _tThe Australasian journal of dermatology
_gvol. 38 Suppl 1
_gp. S66-72
856 4 0 _uhttps://doi.org/10.1111/j.1440-0960.1997.tb01014.x
_zAvailable from publisher's website
999 _c10940818
_d10940818